Drug profile · INN
difelikefalin acetate
KORSUVA
difelikefalin acetate (KORSUVA) is a kappa opioid receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — difelikefalin acetate
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
difelikefalin acetate (KORSUVA) is a kappa opioid receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Kappa opioid receptor agonist
Primary target: Kappa-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is difelikefalin acetate?
difelikefalin acetate (KORSUVA) is a kappa opioid receptor agonist. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for difelikefalin acetate?
KORSUVA is a marketed brand name for difelikefalin acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of difelikefalin acetate?
difelikefalin acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.